108 related articles for article (PubMed ID: 101880)
1. Congeners of DOM: effect of distribution of the evaluation of pharmacologic data.
Barfknecht CF; Caputo JF; Tobin MB; Dyer DC; Standirdge RT; Howell HG; Goodwin WR; Partyka RA; Gylys JA; Cavanagh RL
NIDA Res Monogr; 1978; (22):16-26. PubMed ID: 101880
[No Abstract] [Full Text] [Related]
2. Comparison of the effects of R-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM), r-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) and 5-hydroxytryptamine on non-innervated vascular smooth muscle.
Dyer DC
Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):449-54. PubMed ID: 959651
[TBL] [Abstract][Full Text] [Related]
3. Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP).
Nichols DE; Barfknecht CF; Long JP; Standridge RT; Howell HG; Partyka RA; Dyer DC
J Med Chem; 1974 Feb; 17(2):161-6. PubMed ID: 4809251
[No Abstract] [Full Text] [Related]
4. The effect of chirality on serotonin receptor affinity.
Glennon RA
Life Sci; 1979 Apr; 24(16):1487-92. PubMed ID: 470548
[No Abstract] [Full Text] [Related]
5. Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
Jacob JN; Nichols DE
J Med Chem; 1982 May; 25(5):526-30. PubMed ID: 7086838
[TBL] [Abstract][Full Text] [Related]
6. Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane.
Standridge RT; Howell HG; Gylys JA; Partyka RA; Shulgin AT
J Med Chem; 1976 Dec; 19(12):1400-4. PubMed ID: 1003425
[No Abstract] [Full Text] [Related]
7. Evaluation of substituted-amphetamine hallucinogens using the cat limb flick model.
Rusterholz DB; Spratt JL; Long JP; Barfknecht CF
Commun Psychopharmacol; 1977; 1(6):589-92. PubMed ID: 608329
[No Abstract] [Full Text] [Related]
8. Potent agonist activity of DOB at 5-HT2 receptors in guinea pig trachea.
Heller WA; Baraban JM
Eur J Pharmacol; 1987 Jun; 138(1):115-7. PubMed ID: 3622603
[TBL] [Abstract][Full Text] [Related]
9. The use of rigid analogues to probe hallucinogen receptors.
Nichols DE; Weintraub HJ; Pfister WR; Yim GK
NIDA Res Monogr; 1978; (22):70-83. PubMed ID: 101889
[No Abstract] [Full Text] [Related]
10. [3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.
Titeler M; Herrick K; Lyon RA; McKenney JD; Glennon RA
Eur J Pharmacol; 1985 Oct; 117(1):145-6. PubMed ID: 4085543
[No Abstract] [Full Text] [Related]
11. Characterization of 5-hydroxytryptamine receptors on isolated ovine uterine artery in late pregnancy.
Zhang L; Dyer DC
J Pharmacol Exp Ther; 1990 Jun; 253(3):1236-44. PubMed ID: 2359025
[TBL] [Abstract][Full Text] [Related]
12. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
[No Abstract] [Full Text] [Related]
13. DOM and related 2,5-dimethoxy-4-alkylphenylisopropylamines: behavioral and serotonin receptor properties.
Glennon RA; Doot DL; Young R
Pharmacol Biochem Behav; 1981 Mar; 14(3):287-92. PubMed ID: 7232455
[TBL] [Abstract][Full Text] [Related]
14. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
Sanders-Bush E; Burris KD; Knoth K
J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
[TBL] [Abstract][Full Text] [Related]
15. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
Commissaris RL; Semeyn DR; Moore KE; Rech RH
Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
[No Abstract] [Full Text] [Related]
16. Behavioral changes induced by 2,5-dimethoxy 4-methyl-amphetamine (DOM, STP) in primate dyads.
Tyler CB; Schlemmer RF; Narasimhachari N; Davis JM
Commun Psychopharmacol; 1978; 2(4):337-42. PubMed ID: 103677
[No Abstract] [Full Text] [Related]
17. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
Cheng HC; Long JP; Nichols DE; Barfknecht CF
J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
[No Abstract] [Full Text] [Related]
18. Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity.
Glennon RA; Young R; Jacyno JM
Biochem Pharmacol; 1983 Apr; 32(7):1267-73. PubMed ID: 6573879
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic and dopaminergic involvement in the mechanism of action of R-(-)-2,5-dimethoxy-4-bromoamphetamine (DOB) in cats.
Rusterholz DB; Spratt JL; Long JP; Kelly TF
Life Sci; 1978 Oct; 23(14):1499-506. PubMed ID: 713706
[No Abstract] [Full Text] [Related]
20. Comparative effects of stereoisomers of psychotomimetic phenylisopropylamines.
Dyer DC; Nichols DE; Rusterholz DB; Barfknecht CF
Life Sci; 1973 Oct; 13(7):885-96. PubMed ID: 4766265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
